抑郁症3种药物治疗方案的成本-效果分析  

Cost-effectiveness Analysis of3Therapeutic Regimes for Depression

作　　者：陈伟兰[1] 李瑞珍[1] 李艳芳[1] 邓红珠[1] 

机构地区：[1]中山大学附属第三医院药剂科,广州市510630

出　　处：《中国药房》2006年第9期673-674,共2页China Pharmacy

摘　　要：目的:评价抑郁症3种药物治疗方案的成本-效果。方法:将我院120例门诊抑郁症患者分为A、B、C组,分别给予氯米帕明、帕罗西汀、舍曲林后观察疗效,并运用成本-效果法进行分析。结果:3组成本分别为702、1008、765元,有效率分别为77%、82%、90%(P>0.05),成本-效果比分别为9.12、12.29、8.50。结论:C组方案治疗抑郁症成本-效果比更优。OBJECTIVE： To conduct cost -effectiveness analyses on 3 therapeutic schemes for depression. METHODS： A total of 120 cases with melancholia were ascribed to receive clomipramine （group A）, paroxetine （group B） and sertraline （group C）, respectively, the curative effects were observed analyzed by cost-effectiveness method. RESULTS： The costs for 3 groups were 702 yuan, 1 008 yuan and 765 yuan, respectively, the effective rates were 77%, 82% and 90% （P〉 0.05）, respectively,and the cost- effectiveness ratios were 9.12,12.29 and 8.50, respectively. CONCLUSION： Group C is superior in terms of the cost-effectiveness ratio among the 3 regimes for depression.

关 键 词：氯米帕明 帕罗西汀 舍曲林 抑郁症 成本-效果分析 

分 类 号：R956[医药卫生—药学]